Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12108280 | 0.83 | SLC22A6 (0.34) | SLC22A6TP53 | |
| SCHEMBL10708540 | 0.81 | SLC22A6 (0.43) | SLC22A6CA1TP53BLMLMNA | |
| SCHEMBL11874204 | 0.80 | ALDH1A1 (0.37) | SLC22A6TP53GRIA1 | |
| SCHEMBL11341696 | 0.80 | PTGS1 (0.36) | SLC22A6TP53BLMLMNAGRIA1 | |
| SCHEMBL1773515 | 0.80 | TSHR (0.46) | SLC22A6CA1TP53GRIA1 | |
| SCHEMBL27658493 | 0.78 | SLC22A6 (0.42) | SLC22A6CA1TP53BLMLMNA | |
| SCHEMBL22627092 | 0.78 | LMNA (0.40) | SLC22A6CA1TP53BLMLMNA | |
| SCHEMBL15988236 | 0.77 | SLC22A6 (0.37) | SLC22A6GRIA1 | |
| SCHEMBL21853612 | 0.76 | APP (0.41) | SLC22A6TP53BLMLMNAGRIA1 | |
| SCHEMBL21853613 | 0.76 | APP (0.41) | SLC22A6TP53BLMLMNAGRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1188743-B1 | PROCESS FOR PREPARING ORGANIC SULFUR ACIDS OR SALTS THEREOF | DAICEL CHEM (JP) | 2009-06-17 | — | — | EP | disclosed |
| US-6706915-B2 | USING A METAL COMPOUND AS A CATALYST, A CORRESPONDING ORGANIC SULFONIC ACID OR A SALT CAN BE OBTAINED BY REACTING AN ORGANIC SUBSTRATE WITH A SULFUR OXIDE IN THE ABSENCE OF N-HYDROXY AND N-OXO CYCLIC IMIDE COMPOUNDS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-03-16 | — | — | US | disclosed |
| US-20020161255-A1 | Process for preparing organic sulfur acids or salts thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-10-31 | — | — | US | disclosed |
| EP-1188743-A1 | PROCESS FOR PREPARING ORGANIC SULFUR ACIDS OR SALTS THEREOF | Daicel Chemical Industries, Ltd. (JP) | 2002-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161255-A1 | Process for preparing organic sulfur acids or salts thereof | BHMT2, TST, ICMT | SLC22A6 1797/4885CA1 1161/4885TP53 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.